Full Length Research Paper
References
|
Akujobi CN, Ewuru CP (2010). Detection of Extended Spectrum Beta-Lactamases in Gram Negative Bacilli from Clinical Specimens in a Teaching in South Eastern Nigeria. Nigerian Medical Journal 51:141-146. |
|
|
Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D (2008). Prevalence and Antimicrobial Susceptibility Pattern of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in the United Arab Emirates. Medical Principles and Practice 17(1):32-36. |
|
|
Blomberg B, Jureen R, Manji KP (2005). High Rate of Fatal Pediatric Septicemia caused by Gram-Negative Bacteria with Extended-Spectrum Beta-Lactamases in Dares Salaam, Tanzania. Journal of Clinical Microbiology 43:745-749. |
|
|
Chaudhary U, Aggarwal R (2004). Extended Spectrum Beta Lactamases (ESBL) An Emerging Threat to Clinical Theraputics. Indian Journal of Medical Microbiology 22(2):75-80. |
|
|
Cheesbrough M (2004). District Laboratory Practice in Tropical Countries, Part Two, 2ndEdition. Cambridge University Press, UK, pp. 134-180. |
|
|
Chowdhury MA, Yamanaka H, Miyoshi S, Aziz KM, Shinoda S (1994). Ecology of Vibrio mimicus in Aquatic Environments. Applied and Environmental Microbiology 55(8):2073-2078. |
|
|
CLSI (2014). 24th informational supplement. Clinical and Laboratory Standards Institute (2014). M100-S24 Performance standards for antimicrobial susceptibility testing. |
|
|
Haque R, Salam M (2010). Detection of ESBL Producing Nosocomial Gram Negative Bacteria from a Tertiary Care Hospital in Bangladesh. Pakistan Journal of Medical Sciences 26(4):887-891. |
|
|
Iroha IR, Adikwu MU, Esimone CO, Abinu I, Amadi ES (2009). Exetended Spectrum Beta-Lactamase (ESBL) in Escherichia coli isolated from a Tertiary Hospital in Enugu State, Nigeria. Pakistan Journal of Medical Sciences 25(2):279-282. |
|
|
Lal P, Kapil A, Das B, Sood S (2007). Occurrence of TEM and SHV Genes in Extended Spectrum Beta Lactamases (ESBLs) Producing Klebsiella species isolated from a Tertiary Care Hospital. Indian Journal of Medical Research 125:173-178. |
|
|
Lin Y, Lu M, Hui-Ling C, Tang H, Liu H, Chen C, Liu K, Lin C, Chiou C, Chiang M, Chen C, Yi C, Lai Y (2011). Assessment of hypermucoviscosity as a Virulence Factor for Experimental Klebsiella pneumoniae Infections: Comparative Virulence Analysis with hypermucoviscosity-Negative Strain. Bio Med Central Microbiology 11:50. |
|
|
Livrelli V, Champs CD, Martino PD, Michaud AD, Forestier C, Joly B (1996). Adhesive Properties and Antibiotic Resistance of Klebsiella, Enterobacter and Serratia Clinical Isolates Involved in Nosocomial Infections. Journal of Clinical Microbiology 34(8):1963-1969. |
|
|
Mammeri H, Van De LM, Poirel L, Martinez-Martinez L, Nordmann P (2005). Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrobial Agents Chemotherapy 49:71-76. |
|
|
Miller GH, Sabatelli FJ (1997). The Most Frequent Aminoglycoside Resistance Mechanisms Changes with Time and Geographic Area: a Reflection of Aminoglycoside Usage Patterns? Aminoglycoside Resistance Study Groups. Clinical Infectious Diseases 24(1):46-62. |
|
|
Okesola AO, Fowotade A (2012). Extended-Spectrum Beta-Lactamase Production among Clinical Isolates of Escherichia coli. International Research Journal of Microbiology 3(4):140-143. |
|
|
Paterson DL (2000). Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clinical Microbiology Infection 6:460-463. |
|
|
Paterson DL, Bonomo RA (2005). Extended-spectrum β-lactamases: A clinical update. Clinical Microbiology Review 18:657-686. |
|
|
Paterson DL (2007). Recommendation for Treatment of Severe Infections caused by EnterobacteriaceaeProducing Extended-Spectrum β-Lactamases (ESBLs). Clinical Microbiology and Infection 6:460-463. |
|
|
Perez F, Enridimiani A, Hujer K, Bonomo RA (2007). The continuing challenge of ESBL. Current Opinion in Pharmacology 7(5):459-469. |
|
|
Philippon A, Labia R, Jacoby G (1989). Extended-spectrum beta-lactamases. Antimicrobial Agents Chemotherapy 33:1131-1136. |
|
|
Samaha-Kfoury JN, Araj GF (2003). Recent Developments in β Lactamases and Extended Spectrum β-lactamases. Beirut Medical Journal 327(22):1209-1213. |
|
|
Sasirekha B, Manasa R, Ramya P, Sneha R (2010). Frequency and Antimicrobial Sensitivity Pattern of Extended Spectrum β- Lactamases-Producing Escherichia coli and Klebsiella pneumonia Isolated In A Tertiary Care Hospital, Al Ameen. Journal of Medical Science 3(4):265-271. |
|
|
Shobha KL, Gowrish RS, Sugandhi R, Sreeja CK (2007). Prevalence of Extended Spectrum β-Lactamases in Urinary Isolates of Escherichia coli, Klebsiella and Citrobacter Species and their Antimicrobial Susceptibility Pattern in tertiary care hospital. Indian Journal for the Practicing Doctor 3(6):01-02. |
|
|
Thomson KS (2001). Controversies about Extended-Spectrum and AmpC β-Lactamases. Emerging Infectious Diseases 7:333-336. |
|
|
Ullah F, Malik SA, Ahmed J (2009). Antimicrobial Susceptibility Pattern and ESBL Prevalence in Klebsiella pneumoniae from Urinary Tract Infections in the North. West of Pakistan. African Journal of Microbiology 3(11):670- 680. |
|
|
Yushaꞌu M, Kumurya AS, Suleiman L (2010). Prevalence of Extended spectrum β- lactamases among Enterobacteriaceae in Murtala Mohammed specialist hospital, Kano. Journal of Pure and Applied Sciences 3(1):169-172. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
